Evaluation of the Relative Frequency of Epstein-Barr Virus Infection in Patients with Recurrent Breast Cancer Compared with Patients with Nonrecurrent Breast Cancer

Overview

Journal Adv Biomed Res

Specialty Biomedical Engineering

Date 2023 Apr 14

PMID 37057233

Authors

Reza Eshraghi Samani

Masoumeh Safaee

Pardis Nematollahi

Babak Amraei

Affiliations

Soon will be listed here.

Abstract

Background: The roles of Epstein-Barr virus (EBV) in breast cancer and breast lymphoma by transfecting EBV DNA have been indicated in different studies, but few investigations have been conducted on its roles in recurrence of breast cancer. Here, we aimed to evaluate the roles of EBV in recurrent breast cancer tissue.

Materials And Methods: This is a cross-sectional retrospective study that was performed in 2020-2021 in Isfahan on patients with breast cancer. The study population consisted of 30 tissue samples from recurrent breast cancer and 30 samples from nonrecurrent breast cancer. We collected demographic data of patients including age using a checklist. Other collected data were type of cancer, stages of cancer, tumor size in greatest dimension, lymph node involvements, and presence of metastasis. Furthermore, we evaluated all of the pathology samples from both groups for the presence of DNA of EBV and compared the data of both groups.

Results: The DNA of EBV was positive in 8 patients of the relapsed group (26.6%) and 7 patients in the nonrelapsed patients (23.3%). There was no significant difference between two groups regarding positive DNA of EBV ( = 0.39). There were no significant differences between two groups of positive DNA of EBV with and without recurrent breast cancer regarding type of cancer ( = 0.63), stage of cancer ( = 0.19), tumor size in greatest dimension ( = 0.31), mean lymph node involvement ( = 0.27), number of lymph node involvement ( = 0.43), and metastasis ( = 0.69).

Conclusion: EBV might have no significant role in recurrence of breast cancer.

References

Farahmand M, Monavari S, Shoja Z, Ghaffari H, Tavakoli M, Tavakoli A . Epstein-Barr virus and risk of breast cancer: a systematic review and meta-analysis. Future Oncol. 2019; 15(24):2873-2885. DOI: 10.2217/fon-2019-0232. View

Babak A, Rouzbahani R, Khalili Nejad R, Rafiee Zadeh A . Comparison of Nutritional Behaviors and Physical Activities between Overweight/Obese and Normal-Weight Adults. Adv Biomed Res. 2019; 8:62. PMC: 6839272. DOI: 10.4103/abr.abr_134_19. View

Sancho-Garnier H, Colonna M . [Breast cancer epidemiology]. Presse Med. 2019; 48(10):1076-1084. DOI: 10.1016/j.lpm.2019.09.022. View

Payghani C, Khani F, Rafieezadeh A, Reisi P, Alaei H, Rashidi B . Effects of Levothyroxine on Visual Evoked Potential Impairment Following Local Injections of Lysolecithin into the Rat Optic Chiasm. Int J Prev Med. 2018; 9:18. PMC: 5843963. DOI: 10.4103/ijpvm.IJPVM_418_16. View

Mofrad M, Kazeminezhad B, Faghihloo E . Prevalence of Epstein-Barr virus (EBV) in Iranian Breast Carcinoma Patients. Asian Pac J Cancer Prev. 2020; 21(1):133-137. PMC: 7294004. DOI: 10.31557/APJCP.2020.21.1.133. View

Hosseini J, Fallah-Karkan M, Rahavian A, Soleimanzadeh F, Salimi H, Ghadimi K . Feasibility, complication and long-term follow-up of the newly nelaton based urethral dilation method, retrospective study. Am J Clin Exp Urol. 2020; 7(6):378-383. PMC: 6971477. View

Farrokhi M, Amani Beni A, Etemadifar M, Rezaei A, Rivard L, Rafiee Zadeh A . Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients. Int J Prev Med. 2016; 6:125. PMC: 4736130. DOI: 10.4103/2008-7802.172539. View

Rahimi Varposhti M, Moradi Farsani D, Ghadimi K, Asadi M . Reduction of oculocardiac reflex with Tetracaine eye drop in strabismus surgery. Strabismus. 2019; 27(1):1-5. DOI: 10.1080/09273972.2018.1561732. View

Dunmire S, Verghese P, Balfour Jr H . Primary Epstein-Barr virus infection. J Clin Virol. 2018; 102:84-92. DOI: 10.1016/j.jcv.2018.03.001. View

10.

Labrecque L, Barnes D, Fentiman I, Griffin B . Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 1995; 55(1):39-45. View

11.

Rafiee Zadeh A, Ghadimi K, Ataei A, Askari M, Sheikhinia N, Tavoosi N . Mechanism and adverse effects of multiple sclerosis drugs: a review article. Part 2. Int J Physiol Pathophysiol Pharmacol. 2019; 11(4):105-114. PMC: 6737425. View

12.

Lee S, Jiang X . Modeling miRNA-mRNA interactions that cause phenotypic abnormality in breast cancer patients. PLoS One. 2017; 12(8):e0182666. PMC: 5549916. DOI: 10.1371/journal.pone.0182666. View

13.

Lawson J, Salmons B, Glenn W . Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV). Front Oncol. 2018; 8:1. PMC: 5786831. DOI: 10.3389/fonc.2018.00001. View

14.

Alavi A, Izadpanahi M, Haghshenas L, Faridizad R, Eslami M, Ghadimi K . Comparing urine levels of BLCA-4 nuclear matrix protein in patients with bladder cancer and non-bladder cancer. Int J Physiol Pathophysiol Pharmacol. 2020; 11(6):289-292. PMC: 6971499. View

15.

Sinclair A, Moalwi M, Amoaten T . Is EBV Associated with Breast Cancer in Specific Geographic Locations?. Cancers (Basel). 2021; 13(4). PMC: 7919813. DOI: 10.3390/cancers13040819. View

16.

Rafiee Zadeh A, Askari M, Azadani N, Ataei A, Ghadimi K, Tavoosi N . Mechanism and adverse effects of multiple sclerosis drugs: a review article. Part 1. Int J Physiol Pathophysiol Pharmacol. 2019; 11(4):95-104. PMC: 6737429. View

17.

Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Martin P . Outcome of Epstein-Barr virus-associated primary breast cancer. Mol Clin Oncol. 2015; 3(2):295-298. PMC: 4360834. DOI: 10.3892/mco.2014.459. View

18.

Payghani C, Khani F, Rafiee Zadeh A, Reisi P, Alaei H, Rashidi B . The Effect of Levothyroxine on Serum Levels of Interleukin 10 and Interferon-gamma in Rat Model of Multiple Sclerosis. Adv Biomed Res. 2017; 6:118. PMC: 5627569. DOI: 10.4103/abr.abr_267_16. View

19.

Winters S, Martin C, Murphy D, Shokar N . Breast Cancer Epidemiology, Prevention, and Screening. Prog Mol Biol Transl Sci. 2017; 151:1-32. DOI: 10.1016/bs.pmbts.2017.07.002. View

20.

Moradi Farsani D, Ghadimi K, Abrishamkar R, Montazeri K, Peyman A . Evaluating sedative effects of dexmedetomidine and morphine in the patients with opioid use disorder undergoing cataract surgery. Am J Clin Exp Immunol. 2021; 10(1):30-36. PMC: 8012304. View